Alpha.rar

The most current "solid" update in this field is the development of , a selective RARα antagonist.

: Recent Phase 1a clinical trials published in 2025/2026 show it is safe, well-tolerated, and—most importantly—the sterility it causes is reversible . 🧬 Role in Leukemia (APL) ALPHA.rar

: Researchers have identified an S100A9–ALDH1A1–RA axis that drives brain metastasis in EGFR-mutant lung cancer. Inhibiting RAR receptors has shown potential in dramatically reducing these relapses. The most current "solid" update in this field